4.6 Review

Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis

Journal

CLINICAL MICROBIOLOGY REVIEWS
Volume 24, Issue 1, Pages 29-70

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/CMR.00036-10

Keywords

-

Categories

Funding

  1. Cystic Fibrosis Foundation (CFF)
  2. CFF Therapeutics, Inc.
  3. CFF Therapeutics Development Network
  4. National Institutes of Health [R01 AI053674, R01 AI075191, K02 AI065615, R21 AI088286]
  5. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI065615, R21AI088286, R01AI053674, R01AI075191] Funding Source: NIH RePORTER

Ask authors/readers for more resources

A select group of microorganisms inhabit the airways of individuals with cystic fibrosis. Once established within the pulmonary environment in these patients, many of these microbes adapt by altering aspects of their structure and physiology. Some of these microbes and adaptations are associated with more rapid deterioration in lung function and overall clinical status, whereas others appear to have little effect. Here we review current evidence supporting or refuting a role for the different microbes and their adaptations in contributing to poor clinical outcomes in cystic fibrosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available